info@seagull-health.com
SeagullHealth
语言:
search

How should I use Filspari(Sparsentan)?

Sparsentan is administered orally, starting with 200 mg daily and increased to 400 mg daily after 14 days, with specific dosage adjustments based on liver function.

Recommended Dosage of Sparsentan

The initial dose of Sparsentan is 200 mg once daily. After 14 days, it should be increased to 400 mg once daily, based on patient tolerance. If treatment is resumed after an interruption, re-titration is recommended. The drug should be taken before meals, and missed doses should be taken at the next scheduled time.

Sparsentan(Filspari)
Sparsentan(Filspari)
Adult patients with primary immunoglobulin A nephropathy (IgAN) who are at risk...
WeChat Scan
Free Inquiry
Related articles
Dosage and Administration of Sparsentan (Filspari)
Sparsentan (Filspari) is a dual antagonist of endothelin and angiotensin II receptors, which was first approved in the United States in 2023. This medication is mainly used to slow the decline of rena...
Guidelines for the use of Sparsentan
Sparsentan is a drug used to treat primary immunoglobulin A nephropathy (IgAN) with a risk of rapid disease progression, improving the condition by lowering the patient's proteinuria levels. This ...
How to use Sparsentan?
Sparsentan is a drug used to treat specific types of kidney disease, especially in patients with primary immunoglobulin A nephropathy (IgAN). This article will introduce in detail how to use this drug...
Guidelines for the use of Sparsentan
Sparsentan is a drug used to treat specific types of kidney disease, especially in patients with primary immunoglobulin A nephropathy (IgAN). This article will explore how the drug is used, how well i...
共 4 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved